MedPath

Study of brain damage in newborns with increased sodium levels

Phase 4
Conditions
Health Condition 1: N19- Unspecified kidney failure
Registration Number
CTRI/2019/06/019706
Lead Sponsor
Dr Anurag Singh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Neonates (0 to 28 days) admitted with hypernatremia (serum sodium level >150mEq/l) will be included.

Exclusion Criteria

Neonate with:

1. Congenital malformations.

2. Suspected metabolic disease

3. known case of structural renal disease/previously diagnosed kidney disease

4. History of delayed cry/hypoxic ischemic encephalopathy

5. Sepsis screen or blood culture positive

6. Coagulopathy

7. Previous admission

8. History of abortion or unexplained sibling death in maternal history

9. History of stroke, DVT, early age MI or thromboembolic phenomena in family

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To find out nature of intracranial pathology (brain lesion) in hypernatremic neonates and Correlation with clinical presentation and MRI brain <br/ ><br>Timepoint: Till 28 days of life
Secondary Outcome Measures
NameTimeMethod
To find out correlation between location, number and types of lesion and degree of hypernatremia. <br/ ><br>To find out incidence mri brain changes of hypernatremia in sick neonates admitted in NICU of Umaid hospital.Timepoint: Till 28 days of life.
© Copyright 2025. All Rights Reserved by MedPath